Related references
Note: Only part of the references are listed.Impact of 18F-Labeled Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Versus Conventional Staging in Patients With Locally Advanced Breast Cancer
Ian S. Dayes et al.
JOURNAL OF CLINICAL ONCOLOGY (2023)
2-[18F]FDG-PET/CT is a better predictor of survival than conventional CT: a prospective study of response monitoring in metastatic breast cancer
Marianne Vogsen et al.
SCIENTIFIC REPORTS (2023)
The Role of 68Ga-FAPI PET/CT in Detection of Metastatic Lobular Breast Cancer
Yael Eshet et al.
CLINICAL NUCLEAR MEDICINE (2023)
Comparison of Image Quality and Quantification Parameters between Q.Clear and OSEM Reconstruction Methods on FDG-PET/CT Images in Patients with Metastatic Breast Cancer
Mohammad Naghavi-Behzad et al.
JOURNAL OF IMAGING (2023)
Designing clinical trials based on modern imaging and metastasis-directed treatments in patients with oligometastatic breast cancer: a consensus recommendation from the EORTC Imaging and Breast Cancer Groups
David Pasquier et al.
LANCET ONCOLOGY (2023)
Auto-segmentation of head and neck tumors in positron emission tomography images using non-local means and morphological frameworks
Sahel Heydarheydari et al.
POLISH JOURNAL OF RADIOLOGY (2023)
Automatic Segmentation of Metastatic Breast Cancer Lesions on 18F-FDG PET/CT Longitudinal Acquisitions for Treatment Response Assessment
Noemie Moreau et al.
CANCERS (2022)
16a-18F-fluoro-17b-Fluoroestradiol (FES): Clinical Applications for Patients With Breast Cancer
Gary A. Ulaner
SEMINARS IN NUCLEAR MEDICINE (2022)
NRG-BR002: A phase IIR/III trial of standard of care systemic therapy with or without stereotactic body radiotherapy (SBRT) and/or surgical resection (SR) for newly oligometastatic breast cancer (NCT02364557).
Steven J. Chmura et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
FDG-PET/CT in high-risk primary breast cancer-a prospective study of stage migration and clinical impact
Marianne Vogsen et al.
BREAST CANCER RESEARCH AND TREATMENT (2021)
ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer
A. Gennari et al.
ANNALS OF ONCOLOGY (2021)
Head-to-Head Comparison of Fibroblast Activation Protein Inhibitors (FAPI) Radiotracers versus [18F]F-FDG in Oncology: A Systematic Review
Giorgio Treglia et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Preliminary study of AI-assisted diagnosis using FDG-PET/CT for axillary lymph node metastasis in patients with breast cancer
Zongyao Li et al.
EJNMMI RESEARCH (2021)
Diagnosis of bone metastases in breast cancer: Lesion-based sensitivity of dual-time-point FDG-PET/CT compared to low-dose CT and bone scintigraphy
Jeanette Ansholm Hansen et al.
PLOS ONE (2021)
Benefits and harms of implementing [18F]FDG-PET/CT for diagnosing recurrent breast cancer: a prospective clinical study
Marianne Vogsen et al.
EJNMMI RESEARCH (2021)
Local Treatment in Addition to Endocrine Therapy in Hormone Receptor-Positive and HER2-Negative Oligometastatic Breast Cancer Patients: A Retrospective Multicenter Analysis
Chihwan Cha et al.
BREAST CARE (2020)
The requirements of a specialist breast centre
Laura Biganzoli et al.
BREAST (2020)
Extracranial Stereotactic Body Radiotherapy in Oligometastatic or Oligoprogressive Breast Cancer
Fabian Weykamp et al.
FRONTIERS IN ONCOLOGY (2020)
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
F. Cardoso et al.
ANNALS OF ONCOLOGY (2020)
Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document
Yolande Lievens et al.
RADIOTHERAPY AND ONCOLOGY (2020)
Oligometastatic breast cancer treated with hypofractionated stereotactic radiotherapy: Some patients survive longer than a decade
Michael T. Milano et al.
RADIOTHERAPY AND ONCOLOGY (2019)
PET/CT for Patients With Breast Cancer: Where Is the Clinical Impact?
Gary A. Ulaner
AMERICAN JOURNAL OF ROENTGENOLOGY (2019)
Management of bone health in solid tumours: From bisphosphonates to a monoclonal antibody
Roger von Moos et al.
CANCER TREATMENT REVIEWS (2019)
Metastatic bone disease: Pathogenesis and therapeutic options Up-date on bone metastasis management
Stella D'Oronzo et al.
JOURNAL OF BONE ONCOLOGY (2019)
Deep segmentation networks predict survival of non-small cell lung cancer
Stephen Baek et al.
SCIENTIFIC REPORTS (2019)
Evaluation of a Bayesian penalized likelihood reconstruction algorithm for low-count clinical 18F-FDG PET/CT
Joost te Riet et al.
EJNMMI PHYSICS (2019)
Treatment outcomes of breast cancer liver metastasis treated with stereotactic body radiotherapy
Cem Onal et al.
BREAST (2018)
Role of Fludeoxyglucose in Breast Cancer Treatment Response
David Groheux
PET CLINICS (2018)
FDG-PET/CT for systemic staging of patients with newly diagnosed breast cancer
David Groheux
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
A fully automatic approach for multimodal PET and MR image segmentation in gamma knife treatment planning
Leonardo Rundo et al.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2017)
[18F] Fluorodeoxyglucose (FDG)-Positron Emission Tomography (PET)/Computed Tomography (CT) in Suspected Recurrent Breast Cancer: A Prospective Comparative Study of Dual-Time-Point FDG-PET/CT, Contrast-Enhanced CT, and Bone Scintigraphy
Malene Grubbe Hildebrandt et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer
W. E. E. Eberhardt et al.
ANNALS OF ONCOLOGY (2015)
Cancer Statistics, 2015
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Prognosis for Patients With Metastatic Breast Cancer Who Achieve a No-Evidence-of-Disease Status After Systemic or Local Therapy
Andrew J. Bishop et al.
CANCER (2015)
Association between 18F-FDG uptake and molecular subtype of breast cancer
Kazuhiro Kitajima et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
A multimodality segmentation framework for automatic target delineation in head and neck radiotherapy
Jinzhong Yang et al.
MEDICAL PHYSICS (2015)
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0
Ronald Boellaard et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
18F-FDG PET/CT as a staging procedure in primary stage II and III breast cancer: comparison with conventional imaging techniques
Bas B. Koolen et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Correlation of high 18F-FDG uptake to clinical, pathological and biological prognostic factors in breast cancer
David Groheux et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)
Guidelines for Reporting Reliability and Agreement Studies (GRRAS) were proposed
Jan Kottner et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
The impact of 18F-FDG PET/CT in patients with liver metastases
Siew C. Chua et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)
Share Paper
